BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 26943771)

  • 1. Identification and characterization of lncRNA mediated transcriptional dysregulation dictates lncRNA roles in glioblastoma.
    Li Y; Wang Z; Wang Y; Zhao Z; Zhang J; Lu J; Xu J; Li X
    Oncotarget; 2016 Jul; 7(29):45027-45041. PubMed ID: 26943771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of dysregulated long non-coding RNA expressions in glioblastoma cells.
    Balci T; Yilmaz Susluer S; Kayabasi C; Ozmen Yelken B; Biray Avci C; Gunduz C
    Gene; 2016 Sep; 590(1):120-2. PubMed ID: 27306825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA and mRNA interaction study based on transcriptome profiles reveals potential core genes in the pathogenesis of human glioblastoma multiforme.
    Yan Y; Zhang L; Jiang Y; Xu T; Mei Q; Wang H; Qin R; Zou Y; Hu G; Chen J; Lu Y
    J Cancer Res Clin Oncol; 2015 May; 141(5):827-38. PubMed ID: 25378224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of lncRNA-TF crosstalks and identification of prognostic regulatory feedback loops of glioblastoma using lncRNA/TF-mediated ceRNA network.
    Ji Y; Gu Y; Hong S; Yu B; Zhang JH; Liu JN
    J Cell Biochem; 2020 Jan; 121(1):755-767. PubMed ID: 31478223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA and mRNA expression profiles of glioblastoma multiforme (GBM) reveal the potential roles of lncRNAs in GBM pathogenesis.
    Li Q; Jia H; Li H; Dong C; Wang Y; Zou Z
    Tumour Biol; 2016 Nov; 37(11):14537-14552. PubMed ID: 27604987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation.
    Pastori C; Kapranov P; Penas C; Peschansky V; Volmar CH; Sarkaria JN; Bregy A; Komotar R; St Laurent G; Ayad NG; Wahlestedt C
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8326-31. PubMed ID: 26111795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and functional characterization of lncRNAs acting as ceRNA involved in the malignant progression of glioblastoma multiforme.
    Zhang K; Li Q; Kang X; Wang Y; Wang S
    Oncol Rep; 2016 Nov; 36(5):2911-2925. PubMed ID: 27600337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis.
    Han L; Zhang K; Shi Z; Zhang J; Zhu J; Zhu S; Zhang A; Jia Z; Wang G; Yu S; Pu P; Dong L; Kang C
    Int J Oncol; 2012 Jun; 40(6):2004-12. PubMed ID: 22446686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer.
    Li Y; Chen J; Zhang J; Wang Z; Shao T; Jiang C; Xu J; Li X
    Oncotarget; 2015 Sep; 6(28):25003-16. PubMed ID: 26305674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
    Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic profiling of long non-coding RNA and mRNA expression associated with acquired temozolomide resistance in glioblastoma cells.
    Zeng H; Xu N; Liu Y; Liu B; Yang Z; Fu Z; Lian C; Guo H
    Int J Oncol; 2017 Aug; 51(2):445-455. PubMed ID: 28714520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systems biology of myasthenia gravis, integration of aberrant lncRNA and mRNA expression changes.
    Luo Z; Li Y; Liu X; Luo M; Xu L; Luo Y; Xiao B; Yang H
    BMC Med Genomics; 2015 Mar; 8():13. PubMed ID: 25889429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective Series of Nine Long Noncoding RNAs Associated with Survival of Patients with Glioblastoma.
    Lei B; Yu L; Jung TA; Deng Y; Xiang W; Liu Y; Qi S
    J Neurol Surg A Cent Eur Neurosurg; 2018 Nov; 79(6):471-478. PubMed ID: 29959764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptome profiling of lncRNA and co-expression networks in esophageal squamous cell carcinoma by RNA sequencing.
    Li Y; Shi X; Yang W; Lu Z; Wang P; Chen Z; He J
    Tumour Biol; 2016 Oct; 37(10):13091-13100. PubMed ID: 27449043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A long non-coding RNA signature in glioblastoma multiforme predicts survival.
    Zhang XQ; Sun S; Lam KF; Kiang KM; Pu JK; Ho AS; Lui WM; Fung CF; Wong TS; Leung GK
    Neurobiol Dis; 2013 Oct; 58():123-31. PubMed ID: 23726844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentially expressed LncRNAs as potential prognostic biomarkers for glioblastoma.
    Shao M; Liu W; Wang Y
    Cancer Genet; 2018 Oct; 226-227():23-29. PubMed ID: 30005851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome‑wide DNA methylation regulation analysis of long non‑coding RNAs in glioblastoma.
    Ji J; Zhao L; Zhao X; Li Q; An Y; Li L; Li D
    Int J Mol Med; 2020 Jul; 46(1):224-238. PubMed ID: 32319552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inferring and analyzing module-specific lncRNA-mRNA causal regulatory networks in human cancer.
    Zhang J; Le TD; Liu L; Li J
    Brief Bioinform; 2019 Jul; 20(4):1403-1419. PubMed ID: 29401217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma.
    Li M; Long S; Hu J; Wang Z; Geng C; Ou S
    Aging (Albany NY); 2019 Nov; 11(21):9405-9423. PubMed ID: 31692451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison and analysis of lncRNA-mediated ceRNA regulation in different molecular subtypes of glioblastoma.
    Li Q; Yu Q; Ji J; Wang P; Li D
    Mol Omics; 2019 Dec; 15(6):406-419. PubMed ID: 31584593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.